New research has identified a novel mechanism driving osteosarcoma – an aggressive paediatric bone cancer – providing ...

In this blog, we spoke to Andreia Rogerio, Applied Machine Learning Engineer, about her professional journey and the ...

We use cookies to personalise content and to analyse our traffic and improve our website.

There are thousands of potential conditions that can be tested for through genome sequencing. It was important for us to carefully consider which conditions should be looked for in the Generation ...

Genomics England's very first initiative – sequencing 100,000 genomes from around 85,000 NHS patients affected by rare disease or cancer – is leading to groundbreaking insights and continued findings ...

We're working in partnership with NHS England and the NHS Genomic Medicine Service to develop a personalised and predictive healthcare solution through the use of genomics. Genomic medicine uses ...

Genomics England collaborates with a diverse range of industry partners to accelerate new treatment development. By joining the Research Network, industry partners can unlock access to data in the ...

This short video explains what the Genomics England Research Environment is, how genomic data is de-identified and added to the Research Environment, and how researchers can access this de-identified ...

Genomics England began as a vessel to execute the UK Government's bold plan to sequence 100,000 whole genomes and incorporate genomic medicine into routine care in the NHS, a feat we achieved in 2018 ...

Every year hundreds of babies are born in the UK with rare genetic conditions. Early intervention can enhance the health and quality of life of many of these babies. But these conditions can be hard ...